Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
02:01pm, Monday, 23'rd Sep 2024
Corbus Pharmaceuticals Holdings, Inc. CRBP received reaffirmed buy ratings from both H.C. Wainwright and Oppenheimer this week, with analysts citing the company's diversified pipeline as a key driver
Nasdaq Extends Partnership With Nubank to Grow Latam Banking Presence
12:16pm, Monday, 23'rd Sep 2024
Nasdaq wants to expand its digital bank FinTech presence in Latin America. The tech company agreed to provide its AxiomSL regulatory reporting tool to Nubank, the region's digital banking giant, accor
Alternus Clean Energy outlines plan to regain Nasdaq compliance
09:34am, Monday, 23'rd Sep 2024
Alternus Clean Energy Inc (NASDAQ:ALCE, OTC:ACLEW) announced that it has received a delisting notice from the Nasdaq Stock Market for not meeting the minimum closing bid price requirement under Nasdaq
Nasdaq Expands Digital Bank FinTech Presence in Latin America
03:00am, Monday, 23'rd Sep 2024
Expanded partnership with Nubank reflects rapid growth of banking and payment services in Latin America Over half of Nasdaq's Latin American banking clients have expanded their technology partnership
Bull Market Buys: 2 Nasdaq Stocks to Own for the Long Run
06:20am, Saturday, 21'st Sep 2024
Consumer spending habits have shifted, but essentials like healthcare and key staples remain resilient categories. Intuitive Surgical benefits from market leadership in its niche, a wide moat, and a c
This Metric Says Buy the Dip on These Nasdaq Stocks
04:59am, Saturday, 21'st Sep 2024
The insatiable demand for data center chips could fuel excellent results for Advanced Micro Devices. Google saw double-digit percentage growth in advertising revenue following the launch of its Gemi
Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq
06:00pm, Friday, 20'th Sep 2024
SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received a
AirNet Announces Receipt of Deficiency Letters from Nasdaq
05:00pm, Friday, 20'th Sep 2024
BEIJING , Sept. 20, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. ("AirNet" or the "Company") (Nasdaq: ANTE), today announced that it received two deficiency lette
Super Micro Computer, Inc. Announces Receipt of Non-Compliance Letter from Nasdaq
05:00pm, Friday, 20'th Sep 2024
SAN JOSE, Calif.--(BUSINESS WIRE)--Super Micro Computer, Inc. (NASDAQ:SMCI) (“SMCI” or the “Company”), a Total IT Solution Provider for AI, Cloud, Storage and 5G/Edge, today announced that the
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marke
InMed Receives NASDAQ Delisting Notice, and Confirms it has Filed an Appeal and Obtained a Panel Hearing Date
04:30pm, Friday, 20'th Sep 2024
Vancouver, British Columbia--(Newsfile Corp. - September 20, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline
Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 20'th Sep 2024
BRISBANE, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeut
Maxeon Receives Nasdaq Notification and is Proceeding with Approved Reverse Stock Split
04:15pm, Friday, 20'th Sep 2024
SINGAPORE , Sept. 20, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd.
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 20'th Sep 2024
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic canc
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 20'th Sep 2024
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format
